Alcon, the global leader in eye care and a division of Novartis (NYSE: NVS), has received approval from the US ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE